Of note, some patients with high p53 expression were reported to have wild type TP53. Considering these limitations, in the era of precision medicine, we recommend the molecular study of TP53 as already performed in clinical practice in chronic lymphocytic leukemia. Here, TP53 is linked to B-cell chronic lymphocytic leukemia.